Mettler-Toledo International Inc. (NYSE:MTD) Shares Bought by Assenagon Asset Management S.A.

Assenagon Asset Management S.A. grew its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 45.9% during the 3rd quarter, Holdings Channel reports. The firm owned 32,330 shares of the medical instruments supplier’s stock after buying an additional 10,170 shares during the period. Assenagon Asset Management S.A.’s holdings in Mettler-Toledo International were worth $48,485,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the business. Family Firm Inc. acquired a new stake in Mettler-Toledo International during the 2nd quarter valued at $25,000. Blue Trust Inc. boosted its stake in shares of Mettler-Toledo International by 242.9% during the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after acquiring an additional 17 shares during the last quarter. Rothschild Investment LLC purchased a new stake in Mettler-Toledo International during the 2nd quarter worth about $42,000. Itau Unibanco Holding S.A. purchased a new stake in Mettler-Toledo International during the 2nd quarter worth about $42,000. Finally, Crewe Advisors LLC raised its stake in Mettler-Toledo International by 244.4% in the 2nd quarter. Crewe Advisors LLC now owns 31 shares of the medical instruments supplier’s stock valued at $43,000 after purchasing an additional 22 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares of the company’s stock, valued at approximately $6,884,514. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of the stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christian Magloth sold 1,000 shares of the business’s stock in a transaction on Thursday, August 15th. The stock was sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the transaction, the insider now directly owns 734 shares in the company, valued at approximately $1,044,459.98. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.94% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the subject of a number of recent research reports. Stifel Nicolaus lifted their price target on shares of Mettler-Toledo International from $1,510.00 to $1,550.00 and gave the stock a “buy” rating in a report on Monday, August 5th. Wells Fargo & Company started coverage on shares of Mettler-Toledo International in a research note on Tuesday, August 27th. They issued an “equal weight” rating and a $1,400.00 target price for the company. Evercore ISI increased their price target on Mettler-Toledo International from $1,375.00 to $1,450.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 1st. The Goldman Sachs Group raised their price objective on Mettler-Toledo International from $1,150.00 to $1,300.00 and gave the stock a “neutral” rating in a report on Tuesday, July 9th. Finally, JPMorgan Chase & Co. upped their target price on Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research note on Monday, August 5th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $1,363.75.

Mettler-Toledo International Trading Down 2.0 %

MTD stock opened at $1,293.38 on Friday. The stock has a 50-day moving average price of $1,421.35 and a two-hundred day moving average price of $1,394.57. The company has a market cap of $27.62 billion, a PE ratio of 36.27, a price-to-earnings-growth ratio of 4.24 and a beta of 1.14. Mettler-Toledo International Inc. has a 12-month low of $928.49 and a 12-month high of $1,546.93.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.00 by $0.65. Mettler-Toledo International had a net margin of 20.95% and a negative return on equity of 575.61%. The firm had revenue of $946.75 million during the quarter, compared to the consensus estimate of $929.13 million. During the same quarter in the prior year, the company earned $10.19 EPS. The company’s revenue was down 3.6% on a year-over-year basis. Equities analysts forecast that Mettler-Toledo International Inc. will post 40.35 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.